Article Details

AstraZeneca cancer R&D head marks Imfinzi as 'core backbone' of oncology strategy with ...

Retrieved on: 2022-01-20 19:46:31

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca cancer R&D head marks Imfinzi as 'core backbone' of oncology strategy with .... View article details on hiswai:

Excerpt

In the increasingly crowded cancer immunotherapy field, AstraZeneca's Imfinzi has mostly been used in stage III non-small cell lung cancer.

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up